Importance: Recently, the red hair variants of MC1R were found to contribute differently to pigmentation phenotype in males and females. Objective: To investigate the role of these variants in melanoma risk in males and females separately because carriers of the red hair variants of MC1R are at increased risk of melanoma. Design, Setting, and Participants: In this hospital-based, case-control study, we evaluated the effect of MC1R and melanoma risk for males and females separately by performing multivariate logistic regression analyses. Main Outcomes and Measures: Association of MC1R variants and melanoma risk in males and females. Results: A total of 905 females (473 melanoma cases, 432 controls) and 886 males (518 melanoma cases, 368 controls) were included in the analyses. The mean (SD) age of the study population was 59.2 (15.6). In females, carrying any MC1R red hair variants remained an independent risk factor of melanoma in a multivariable analysis (adjusted odds ratio [OR], 2.19 [95% CI, 1.60-2.99]), whereas in males, only signs of actinic skin damage (lentigines on the back [OR, 2.56; 95% CI, 1.47-4.45; P = .001] and the hands [OR, 2.31; 95% CI, 1.24-4.29; P = .008] and wrinkling on the neck [OR, 2.17; 95% CI, 1.23-3.82; P = .007]) and sunburns (OR, 1.65; 95% CI, 1.12-2.42; P = .01) remained significant risk factors. Conclusions and Relevance: MC1R variants contribute differently to melanoma risk in males and females. This could be helpful to better classify melanoma risk factors between the sexes.
Importance: Recently, the red hair variants of MC1R were found to contribute differently to pigmentation phenotype in males and females. Objective: To investigate the role of these variants in melanoma risk in males and females separately because carriers of the red hair variants of MC1R are at increased risk of melanoma. Design, Setting, and Participants: In this hospital-based, case-control study, we evaluated the effect of MC1R and melanoma risk for males and females separately by performing multivariate logistic regression analyses. Main Outcomes and Measures: Association of MC1R variants and melanoma risk in males and females. Results: A total of 905 females (473 melanoma cases, 432 controls) and 886 males (518 melanoma cases, 368 controls) were included in the analyses. The mean (SD) age of the study population was 59.2 (15.6). In females, carrying any MC1R red hair variants remained an independent risk factor of melanoma in a multivariable analysis (adjusted odds ratio [OR], 2.19 [95% CI, 1.60-2.99]), whereas in males, only signs of actinic skin damage (lentigines on the back [OR, 2.56; 95% CI, 1.47-4.45; P = .001] and the hands [OR, 2.31; 95% CI, 1.24-4.29; P = .008] and wrinkling on the neck [OR, 2.17; 95% CI, 1.23-3.82; P = .007]) and sunburns (OR, 1.65; 95% CI, 1.12-2.42; P = .01) remained significant risk factors. Conclusions and Relevance: MC1R variants contribute differently to melanoma risk in males and females. This could be helpful to better classify melanoma risk factors between the sexes.
Authors: J S Palmer; D L Duffy; N F Box; J F Aitken; L E O'Gorman; A C Green; N K Hayward; N G Martin; R A Sturm Journal: Am J Hum Genet Date: 2000-01 Impact factor: 11.025
Authors: Patrick Sulem; Daniel F Gudbjartsson; Simon N Stacey; Agnar Helgason; Thorunn Rafnar; Kristinn P Magnusson; Andrei Manolescu; Ari Karason; Arnar Palsson; Gudmar Thorleifsson; Margret Jakobsdottir; Stacy Steinberg; Snaebjörn Pálsson; Fridbert Jonasson; Bardur Sigurgeirsson; Kristin Thorisdottir; Rafn Ragnarsson; Kristrun R Benediktsdottir; Katja K Aben; Lambertus A Kiemeney; Jon H Olafsson; Jeffrey Gulcher; Augie Kong; Unnur Thorsteinsdottir; Kari Stefansson Journal: Nat Genet Date: 2007-10-21 Impact factor: 38.330
Authors: Richard A Sturm; David L Duffy; Neil F Box; Wei Chen; Darren J Smit; Darren L Brown; Jennifer L Stow; J Helen Leonard; Nicholas G Martin Journal: Pigment Cell Res Date: 2003-06
Authors: Arjen Joosse; Sandra Collette; Stefan Suciu; Tamar Nijsten; Poulam M Patel; Ulrich Keilholz; Alexander M M Eggermont; Jan Willem W Coebergh; Esther de Vries Journal: J Clin Oncol Date: 2013-05-20 Impact factor: 44.544
Authors: R Smith; E Healy; S Siddiqui; N Flanagan; P M Steijlen; I Rosdahl; J P Jacques; S Rogers; R Turner; I J Jackson; M A Birch-Machin; J L Rees Journal: J Invest Dermatol Date: 1998-07 Impact factor: 8.551
Authors: Devarati Mitra; Xi Luo; Ann Morgan; Jin Wang; Mai P Hoang; Jennifer Lo; Candace R Guerrero; Jochen K Lennerz; Martin C Mihm; Jennifer A Wargo; Kathleen C Robinson; Suprabha P Devi; Jillian C Vanover; John A D'Orazio; Martin McMahon; Marcus W Bosenberg; Kevin M Haigis; Daniel A Haber; Yinsheng Wang; David E Fisher Journal: Nature Date: 2012-10-31 Impact factor: 49.962
Authors: Tze-An Yuan; Yunxia Lu; Karen Edwards; James Jakowatz; Frank L Meyskens; Feng Liu-Smith Journal: Int J Environ Res Public Health Date: 2019-03-13 Impact factor: 3.390
Authors: F E Lira; S Podlipnik; M Potrony; G Tell-Martí; N Calbet-Llopart; A Barreiro; C Carrera; J Malvehy; S Puig Journal: Br J Dermatol Date: 2019-05-13 Impact factor: 9.302
Authors: Tongwu Zhang; Jiyeon Choi; William J Pavan; Kevin M Brown; Michael A Kovacs; Jianxin Shi; Mai Xu; Alisa M Goldstein; Adam J Trower; D Timothy Bishop; Mark M Iles; David L Duffy; Stuart MacGregor; Laufey T Amundadottir; Matthew H Law; Stacie K Loftus Journal: Genome Res Date: 2018-10-17 Impact factor: 9.043